flobufen

antirheumatic drug

Also Known As:

4-(2,4-difluorbiphenylyl)-4-oxo-2-methylbutanoic acid; VUFB 16066; VUFB-16066; (1,1'-Biphenyl)-4-butanoic acid, 2',4'-difluoro-alpha-methyl-gamma-oxo-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Butyrates: 2613
      - flobufen: 1
Lipids: 114793
- Fatty Acids: 27405
  - Volatile Fatty Acids: 3052
    - Butyrates: 2613
      - flobufen: 1

Related Diseases

1.	Rheumatoid Arthritis 05/01/1997 - "The beneficial antiarthritic effect of VUFB-16066 has been also confirmed in patients with rheumatoid arthritis."
2.	Experimental Arthritis 05/01/1997 - "In the model of adjuvant arthritis VUFB-16066 improves most of disease symptoms including immunopathological disturbances, which indicates possible disease-modifying activity of the drug. "